Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Offidani

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|March 2, 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapiesMichele Cavo, Sara Bringhen, Gabriele Buda, et al.
Health and Quality of Life Outcomes|June 20, 2018
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocolFabio Efficace, Mario Boccadoro, Antonio Palumbo, et al.
Frontiers in Oncology|February 9, 2023
Experts' consensus on the definition and management of high risk multiple myelomaChiara Marcon, Valentina Simeon, Paola Deias, et al.
Annals of Hematology|March 26, 2011
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myelomaMassimo Offidani, Laura Corvatta, Claudia Polloni, et al.
Leukemia & Lymphoma|February 17, 2012
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myelomaMassimo Offidani, Claudia Polloni, Federica Cavallo, et al.
Transfusion|January 10, 2003
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees CMauro Montanari, Debora Capelli, Antonella Poloni, et al.
Vascular Health and Risk Management|October 1, 2021
Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" ExperienceSerena Rupoli, Alessandro Fiorentini, Erika Morsia, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
British Journal of Haematology|January 20, 2007
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scansAnna Mele, Massimo Offidani, Giuseppe Visani, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|March 2, 2026
Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapiesMichele Cavo, Sara Bringhen, Gabriele Buda, et al.
Health and Quality of Life Outcomes|June 20, 2018
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocolFabio Efficace, Mario Boccadoro, Antonio Palumbo, et al.
Frontiers in Oncology|February 9, 2023
Experts' consensus on the definition and management of high risk multiple myelomaChiara Marcon, Valentina Simeon, Paola Deias, et al.
Annals of Hematology|March 26, 2011
Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myelomaMassimo Offidani, Laura Corvatta, Claudia Polloni, et al.
Leukemia & Lymphoma|February 17, 2012
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myelomaMassimo Offidani, Claudia Polloni, Federica Cavallo, et al.
Transfusion|January 10, 2003
Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80 degrees CMauro Montanari, Debora Capelli, Antonella Poloni, et al.
Vascular Health and Risk Management|October 1, 2021
Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" ExperienceSerena Rupoli, Alessandro Fiorentini, Erika Morsia, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
British Journal of Haematology|January 20, 2007
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scansAnna Mele, Massimo Offidani, Giuseppe Visani, et al.
Pageof 15